Medical Advocates

HAART/ART
/cART
 
Viral Dynamics
               
General Reports
Viral Rebound          




 







 

HAART Main Page Main New/Newsworthy  Home Page      

Last Update:  April 05, 2018  
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports
 

     Journal Papers, Abstracts, and Commentaries 

 
Impact of Antiretroviral Regimens on CSF Viral Escape in a Prospective Multicohort Study of ART-Experienced HIV-1 Infected Adults in the United States.
Mukerji SS, Misra V, Lorenz DR, et al 
Clin Infect Dis
. 2018 Apr 3.
 
Abstract

FULL-TEXT ARTICLE
Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.
Jean Louis F, Buteau J, Franšois K,
LoS One
. 2018 Jan 30;13
Paper

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
HIV Med. 2017 Jul 25
Abstract

HIV viral load suppression in adults and children receiving antiretroviral therapy - results from the IeDEA collaboration.
J
iamsakul A, Kariminia A, Althoff KN, et al
J Acquir Immune Defic Syndr
. 201
7 Jul 8.
Abstract

Virologic failure is uncommon after treatment initiation during acute HIV infection.
Crowell TA, Phanuphak N, Pinyakorn S, et al
AIDS
. 2016 May
 9.
Abstract

Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study
Kamara DA, Smith C, Ryom L, Reiss P, et al
Antivir Ther
. 2016 Apr 26.
Abstract

The Contribution of Missed Clinic Visits to Disparities in HIV Viral Load Outcomes.
Zinski A, Westfall AO, Gardner LI,  et al

Am J Public Health
. 2015 Aug 13:e1-e8
Abstract

Extraordinary heterogeneity of virological outcomes in Patients Receiving HAART and Monitored with the World Health Organization (WHO) Public Health Approach in sub-Saharan Africa and south-east Asia.
Aghokeng AF, Monleau M, Eymard-Duvernay S, et al
Clin Infect Dis. 2013 Sep 27.
Abstract

FULL-TEXT ARTICLE
Timeliness of Clinic Attendance Is a Good Predictor of Virological Response and Resistance to Antiretroviral Drugs in HIV-Infected Patients.
Bastard M, Pinoges L, Balkan S,
PLoS One. 2012;7(11):e49091.
Paper

Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared to Subtype B.
Scherrer AU, Ledergerber B, von Wyl V, et al

Clin Infect Dis
. 2011 Oct 13.
Abstract

Food Insecurity is Associated with Poor Virologic Response among HIV-Infected Patients Receiving Antiretroviral Medications.
Wang EA, McGinnis KA, Fiellin DA, et al

J Gen Intern Med
. 2011 May 15.
Abstract

Virologic and immunologic response to HAART, by age and regimen class.
Althoff KN, Justice AC, Gange SJ, et al

AIDS
. 2010 Sep 8.
Abstract

The Effect of HAART on HIV RNA Trajectory Among Treatment-na´ve Men and Women: A Segmental Bernoulli/Lognormal Random Effects Model With Left Censoring.
Chu H, Gange SJ, Li X,  et al
 
Epidemiology
. 2010 Apr 7.
Abstract

Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline.
Kilby JM, Lee HY, Hazelwood JD, et al

AIDS. 2008 May 11;22(8):957-62.
Abstract
 

Psychiatric Illness and Virologic Response in Patients Initiating Highly Active Antiretroviral Therapy.
Pence BW, Miller WC, Gaynes BN, Eron JJ Jr.
J Acquir Immune Defic Syndr. 2006 Nov 30;
 Abstract

Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline.
Kilby JM, Lee HY, Hazelwood JD, et al

AIDS. 2008 May 11;22(8):957-62.

Abstract
 

Rate of Viral Evolution and Risk of Losing Future Drug Options in Heavily Pretreated, HIV-Infected Patients Who Continue to Receive a Stable, Partially Suppressive Treatment
Regimen.
Hatano H, Hunt P, Weidler J, et al 

Clin Infect Dis.
2006 Nov 15;43(10):1329-36.
Abstract
 
Discordant immunological and virological responses to antiretroviral therapy.
Schechter M, Tuboi SH.
Antimicrob Chemother. 2006 Jul 19;
Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
Regional Changes Over Time in Initial Virologic Response Rates to Combination Antiretroviral Therapy Across Europe.
Bannister WP, Kirk O, Gatell JM, et al 
J Acquir Immune Defic Syndr. 2006 Jun;42(2):229-237.
Abstract
 
Factors Associated with Poor Immunologic Response to Virologic Suppression by Highly Active Antiretroviral Therapy in HIV-Infected Women.
Vaamonde CM, Hoover DR, Anastos K, et al
AIDS Res Hum Retroviruses. 2006 Mar;22(3):222-31.
Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT ARTICLE

Viral Load Responses to HAART is an Independent Predictor of a New AIDS Event in Late Stage HIV Infected Patients: Prospective Cohort Study.
Kazanjian P, Amin K, Brown M, Wei W.
J Transl Med. 2005 Oct 31;3(1):40 [
PDF Paper
 
An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002.
Moore RD, Keruly JC, Gebo KA, Lucas GM.
J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):195-8.
Abstract
 
Time to Virological Failure of 3 Classes of Antiretrovirals after Initiation of Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study Group.
Mocroft A, Ledergerber B, Viard JP, et  al.
 J Infect Dis.
2004 Dec 1;190(11):1947-1956.
Abstract

Long-Term CD4+ T-Cell Response to Highly Active Antiretroviral Therapy According to Baseline  CD4+ T-Cell Count.
Garcia F, De Lazzari E, Plana M, et al
  J
Acquir Immune Defic Syndr.
2004 Jun 1;36(2):702-713.
Abstract

Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection.
Kaufmann GR, Khanna N, Weber R, et al 
Antivir Ther. 2004 Apr;9(2):263-74.
Abstract

CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAART.
Scott-Algara D, Aboulker JP, Durier C, et al.
Clin Exp Immunol
2001 Nov;126(2):295-303

Abstract
 

  HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
Phillips AN, Staszewski S, Weber R, et al
JAMA. 2001 Nov 28;286(20):2560-7.
Abstract

     Conference Reports, Abstracts, and Posters

 
Using the yearly proportion of patients with undetectable viral load - a WHO indicator of HAART effectiveness - in a middle-income country
S. Tuboi, A. Pacheco, S. May, et al
(5th IAS Conference)
Abstract
 
POWERPOINT POSTER PRESENTATION
Virologic response to HAART among incarcerated HIV+ individuals
D Wohl 
(
XVII International AIDS Conference)
Poster Presentation
 
Treatment History but not Previous Genotype Improves the Accuracy of Predicting Virologic Response to HIV Therapy
B. LARDER, D. WANG, A. REVELL ,  et al
(46 ICAAC)  
Abstract

Durability of HAART Regimens over Time
(41 ICAAC)  
Abstract


Viral Rebound
 

     Journal Papers, Abstracts, and Commentaries

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1
patients: a prospective cohort study. Swiss HIV Cohort Study.

Ledergerber B, Egger M, Opravil M, et al.
Lancet. 1999 Mar 13;353(9156):863-8.
Abstract
Magnitude of Virologic Blips Is Associated With a Higher Risk for Virologic Rebound in HIV-Infected Individuals: A Recurrent Events Analysis.
Grennan JT, Loutfy MR, Su D,  et al
J Infect Dis
. 2012 Apr;205(8):1230-1238
Abstract

Plasma HIV-1 RNA Detection Below 50 Copies/mL and Risk of Virologic Rebound in Patients Receiving Highly Active Antiretroviral Therapy.
Doyle T, Smith C, Vitiello P, et al
Clin Infect Dis. 2012 Jan 11.
Abstract

Virological rebound after suppression on highly active antiretroviral therapy.
Mocroft A, Ruiz L, Reiss P
AIDS. 2003 Aug 15;17(12):1741-1751.
Abstract
 

  Consecutive rebounds in plasma viral load are associated with virological failure at 52 weeks among HIV-infected patients.
Raboud JM, Rae S, Woods R, et al
AIDS. 2002 Aug 16;16(12):1627-32.
Abstract
 
  Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?
Moore AL, Youle M, Lipman M, et al.
AIDS
. 2002 Mar 8;16(4):615-8.
Abstract


HAART Main Page Main New/Newsworthy  Home Page      

HAART/ART Viral Dynamics